ACC2011:迷走神经节消融治疗长期持续性房颤

2011-05-07 MedSci原创 MedSci原创

     背景:迷走神经节消融(GP)对长期持续性房颤患者的治疗效果仍未明确。     方法:89名有症状、药物治疗无效的持续性房颤患者接受左心房迷走神经节区域的解剖消融(男性71名;年龄56±7)。之后29名患者接受环肺静脉隔离术的二次消融,其中5名患者进行第三次CPVI。  &nbsp

     背景:迷走神经节消融(GP)对长期持续性房颤患者的治疗效果仍未明确。
     方法:89名有症状、药物治疗无效的持续性房颤患者接受左心房迷走神经节区域的解剖消融(男性71名;年龄56±7)。之后29名患者接受环肺静脉隔离术的二次消融,其中5名患者进行第三次CPVI。
     结果:末次消融后随访16±7个月,53(59.8%)名患者在未服用抗心律失常药物治疗的情况下恢复窦性心律,5 (5.6%)名患者诊断为永久性房颤,31 (34.8%)名患者诊断为阵发性房颤。随访超过24±3个月后,仅接受GP单次消融的患者长期成功率为38.2%。左心房直径[HR 1.039 (1.00-1.07), P = 0.028]和术前房颤持续时间[HR 1.116 (1.02-1.22), P = 0.008]为远期心律失常复发的独立预测因素。
     结论:38.2%的慢性房颤患者接受GP消融后能长期维持窦性节律。随访16±7个月,采用CPVI进行再次消融的成功率为59.6%。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=37316, encodeId=d91d3e31652, content=Wonderful expnolatian of facts available here., beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mahadev, createdTime=Sun Sep 27 06:40:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922508, encodeId=76c41922508e3, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Oct 06 06:11:00 CST 2011, time=2011-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324735, encodeId=e92d1324e351d, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421528, encodeId=45521421528cc, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597696, encodeId=25ba159e69632, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=)]
    2015-09-27 mahadev

    Wonderful expnolatian of facts available here.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=37316, encodeId=d91d3e31652, content=Wonderful expnolatian of facts available here., beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mahadev, createdTime=Sun Sep 27 06:40:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922508, encodeId=76c41922508e3, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Oct 06 06:11:00 CST 2011, time=2011-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324735, encodeId=e92d1324e351d, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421528, encodeId=45521421528cc, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597696, encodeId=25ba159e69632, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=37316, encodeId=d91d3e31652, content=Wonderful expnolatian of facts available here., beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mahadev, createdTime=Sun Sep 27 06:40:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922508, encodeId=76c41922508e3, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Oct 06 06:11:00 CST 2011, time=2011-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324735, encodeId=e92d1324e351d, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421528, encodeId=45521421528cc, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597696, encodeId=25ba159e69632, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=37316, encodeId=d91d3e31652, content=Wonderful expnolatian of facts available here., beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mahadev, createdTime=Sun Sep 27 06:40:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922508, encodeId=76c41922508e3, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Oct 06 06:11:00 CST 2011, time=2011-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324735, encodeId=e92d1324e351d, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421528, encodeId=45521421528cc, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597696, encodeId=25ba159e69632, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=37316, encodeId=d91d3e31652, content=Wonderful expnolatian of facts available here., beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mahadev, createdTime=Sun Sep 27 06:40:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922508, encodeId=76c41922508e3, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Thu Oct 06 06:11:00 CST 2011, time=2011-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324735, encodeId=e92d1324e351d, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421528, encodeId=45521421528cc, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597696, encodeId=25ba159e69632, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Mon May 09 01:11:00 CST 2011, time=2011-05-09, status=1, ipAttribution=)]